Preventing influenza in younger children

Clinical Microbiology and Infection

Volumn 18, Issue SUPPL. 5, 2012, Pages 42-49

  Esposito, S ^a   Tagliabue, C ^a   Tagliaferri, L ^a   Semino, M ^a   Longo, M R ^a   Principi, N ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adjuvanted influenza vaccine; Children; Influenza; Influenza vaccine; Live attenuated influenza vaccine

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MIFAMURTIDE; PLACEBO; VIROSOME; VIROSOME VACCINE;

2009 H1N1 INFLUENZA; ANTIBODY PRODUCTION; B LYMPHOCYTE; BRONCHOSPASM; CELLULAR IMMUNITY; CHILD; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG TOLERABILITY; EPIDEMIC; FEVER; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION CONTROL; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; MEDICAL EXAMINATION; META ANALYSIS (TOPIC); MUCOSAL IMMUNITY; NONHUMAN; PANDEMIC; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SEROCONVERSION; SOCIOECONOMICS; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; WHEEZING;

EID: 84867402144     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03942.x     Document Type: Review

References (75)

1. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18: 64-76.
2. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225-231.
3. Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-239.
4. Neuzil KM, Zhu Y, Griffin MR et al. Burden of interpandemic influenza in children younger than 5years: a 25-year prospective study. J Infect Dis 2002; 185: 147-152.
5. Heikkinen T, Silvennoinen H, Peltola V et al. Burden of influenza in children in the community. J Infect Dis 2004; 190: 1369-1373.
6. Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355: 31-40.
7. Esposito S, Marchisio P, Principi N. The global state of influenza in children. Pediatr Infect Dis J 2008; 27 (11 Suppl.): S149-S153.
8. Centers for Disease Control Prevention. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59 (RR-8): 1-62.
9. European CDC. Seasonal influenza vaccines 2011. Available at: http://ecdc.europa.eu/en/healthtopics/seasonalinfluenza/vaccines/Pages/influenzavaccination.aspx. Accessed December 12, 2011.
10. Monto AS. Seasonal influenza and vaccination coverage. Vaccine 2010; 28: D33-D44.
11. Heikkinen T, Booy R, Campins M et al. Should healthy children be vaccinated against influenza? A consensus report of the summits of Independent European vaccination experts. Eur J Pediatr 2006; 165: 223-228.
12. Usonis V, Anca I, Andre F et al. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children. BMC Infect Dis 2010; 10: 168.
13. Principi N, Esposito S. Pediatric influenza prevention and control. Emerg Infect Dis 2004; 10: 574-580.
14. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009; 58: 446-458.
15. Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006; 24: 4934-4941.
16. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008; 2: CD004879.
17. Manzoli L, Schioppa F, Boccia A, Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 2007; 26: 97-106.
18. Esposito S, Principi N. The rational use of influenza vaccines in healthy children and children with underlying conditions. Curr Opin Infect Dis 2009; 22: 244-249.
19. Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA. Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23months of age: do children of all ages respond equally? Vaccine 2010; 28: 4376-4383.
20. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 2004; 23: 189-200.
21. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991; 163: 300-304.
22. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991; 145: 445-448.
23. Gruber WC, Taber LH, Glezen P et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child 1990; 144: 595-600.
24. Hoberman A, Greenberg DP, Paradise JL et al. Efficacy of inactivated influenza vaccine in preventing acute otitis media (AOM) in children. JAMA 2003; 290: 1608-1616.
25. Marchetti M, Kühnel UM, Colombo GL, Esposito S, Principi N. Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60months of age. Hum Vaccin 2007; 3: 14-22.
26. Heikkinen T, Heinonen S. Effectiveness and safety of influenza vaccination in children: European perspective. Vaccine 2011; 29: 7529-7234.
27. Shuler CM, Iwamoto M, Buxton Bridges C et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59months, 2003-2004. Pediatrics 2007; 119: e587.
28. Szilagyi PG, Fairbrother G, Griffin MR et al. Influenza vaccine effectiveness among children 6 to 59months of age during 2 influenza seasons. Arch Pediatr Adolesc Med 2008; 162: 943-951.
29. Eisenberg KW, Szilagyi PG, Fairbrother G et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008; 122: 911-919.
30. Joshi AY, Iyer VN, St Sauver JL, Jacobson RM, Boyce TG. Effectiveness of inactivated influenza vaccine in children less than 5years of age over multiple influenza seasons: a case-control study. Vaccine 2009; 27: 4457-4461.
31. Cochran LW, Black S, Klein NP, Dekker CL, Lewis E, Reingold AL. Vaccine effectiveness against laboratory-confirmed influenza in infants: a matched case control study. Hum Vaccin 2010; 6: 729-735.
32. Heinonen S, Silvennoinen H, Lehtinen P, Vainionpaa R, Ziegler T, Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9months to 3years: an observational cohort study. Lancet Infect Dis 2011; 11: 23-29.
33. Katayose M, Hosoya M, Haneda T et al. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons. Vaccine 2011; 29: 1844-1849.
34. Kelly H, Jacoby P, Dixon GA et al. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J 2011; 30: 107-111.
35. Belongia EA, Kieke BA, Donahue JG et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199: 159-167.
36. Engler RJ, Nelson MR, Klote MM et al. Half- vs full-dose trivalent influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008; 168: 2405-2414.
37. Skowronski DM, Hottes TS, Chong M et al. Randomized controlled trial of dose-response to influenza vaccine in children 6-23months of age. Pediatrics 2011; 128: e276-e289.
38. Esposito S, Daleno C, Picciolli I et al. Immunogenicity and safety of intradermal influenza vaccine in children. Vaccine 2011; 29: 7606-7610.
39. Herzog C, Hartmann C, Künzi V et al. Eleven years of Inflexal® V - a virosomal adjuvanted influenza vaccine. Vaccine 2009; 27: 4381-4387.
40. Kanra G, Marchisio P, Feiterna-Sperling C et al. Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children. Pediatr Infect Dis J 2004; 23: 300-306.
41. Esposito S, Marchisio P, Ansaldi F et al. A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35months. Vaccine 2010; 28: 6137-6144.
42. Salleras L, Domínguez A, Pumarola T et al. Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14years: a prospective cohort study. Vaccine 2006; 24: 6638-6642.
43. Esposito S, Marchisio P, Bosis S et al. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine 2006; 24: 629-635.
44. Vesikari T, Pellegrini M, Karvonen A et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr Infect Dis J 2009; 28: 563-571.
45. Vesikari T, Groth N, Karvonen A, Borkowski A, Pellegrini M. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. Vaccine 2009; 27: 6291-6295.
46. Vesikari T, Knuf M, Wutzler P et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011; 365: 1406-1416.
47. Esposito S, Pugni L, Daleno C et al. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23months. Pediatrics 2011; 127: e1161-e1168.
48. Carmona A, Omenaca F, Tejedor JC et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35months. Vaccine 2010; 28: 5837-5844.
49. World Health Organization. Global advisory committee on vaccine safety: statement on narcolepsy and vaccination. Geneva: WHO. Available at: http://www.who.intvaccinesafety/topics/influenza/pandemic/h1n1 safetyassessing/narcolepsy february2011/en/; 2011. Accessed March 23, 2011.
50. Centers for Disease Control Prevention(CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60: 1128-1132.
51. European Medicine Agency. Fluenz Influenza Vaccine. Authorization Details Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001101/human_med_001405.jsp&mid=WC0b01ac058001d125&murl=menus/medicines/medicines.jsp&jsenabled=true. Accessed October 24, 2011.
52. Belshe RB, Mendelman PM, Treanor J et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998; 338: 1405-1412.
53. Belshe RB, Gruber WC, Mendelman PM et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000; 136: 168-175.
54. Tam JS, Capeding MR, Lum LC et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 2007; 26: 619-628.
55. Vesikari T, Fleming DM, Aristegui JF et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006; 118: 2298-2312.
56. Bracco H, Farhat CK, Tregnaghi MW et al. Efficacy and safety of one and two doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J 2009; 28: 365-371.
57. Forrest BD, Pride MW, Dunning AJ et al. Correlation of cellular immune responses with protection against culture-confirmed influenza in young children. Clin Vaccine Immunol 2008; 15: 1042-1053.
58. Rhorer J, Ambrose CS, Dickinson S et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009; 27: 1101-1110.
59. Belshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356: 685-696 [Erratum in: N Engl J Med 2007; 356:1283].
60. Ashkenazi S, Vertruyen A, Arístegui J et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006; 25: 870-879.
61. Fleming D, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25: 860-869.
62. Vesikari T, Karvonen A, Smith HM et al. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6months of age. Pediatrics 2008; 121: e568-e573.
63. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 1980; 142: 844-849.
64. Mbawuike IN, Six HR, Cate TR, Couch RB. Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes. J Virol 1990; 64: 1370-1374.
65. Sweet C, Jakeman KJ, Smith H. Role of milk-derived IgG in passive maternal protection of neonatal ferrets against influenza. J Gen Virol 1987; 68: 2681-2686.
66. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993; 168: 647-656.
67. Puleston RL, Bugg G, Hoschler K et al. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy. Health Technol Assess 2010; 14: 1-82.
68. Zuccotti G, Pogliani L, Pariani E, Amendola A, Zanetti A. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. JAMA 2010; 304: 2360-2361.
69. Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359: 1555-1564 Erratum in: N Engl J Med. 2009; 360: 648.
70. Poehling KA, Szilagyi PG, Staat MA et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011; 204 (Suppl 1): S141-S148.
71. Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010; 51: 1355-1361.
72. Eick AA, Uyeki TM, Klimov A et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011; 165: 104-111.
73. Esposito S, Bosis S, Morlacchi L, Baggi E, Sabatini C, Principi N. Can infants be protected by means of maternal vaccination? Clin Microbiol Infect 2012: 18 (Suppl. 5): 85-92.
74. Centers for Disease Control Prevention. Influenza vaccination coverage among pregnant women - United States, 2010-2011 influenza season. MMWR Morb Mortal Wkly Rep 2011; 60: 1078-1082.
75. Mereckiene J, Cotter S, Nicoll A et al. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill 2008; 13: 43.